Priority 14 from the Myeloma (Canada) PSP
UNCERTAINTY: How can we restore myeloma patients' immune functioning (e.g., IgG treatment) so that they might resume their daily activities (e.g., travel, work) without fear of infections? (JLA PSP Priority 14) | |
---|---|
Overall ranking | 14 |
JLA question ID | 0113/14 |
Explanatory note | Participants worried about the effects of myeloma treatment on patients' immune system and the resulting impact on their daily activities including working, socializing, and travelling. Some expressed a fear of infection and wanted more information on the use of IgG treatment, mask wearing, and vaccinations, as well as new treatments that do not supress the immune system. |
Evidence |
No evidence identified |
Health Research Classification System category | Cancer and neoplasms |
Extra information provided by this PSP | |
---|---|
Original uncertainty examples | How can you disable the immune system with the drugs that slow the growth of this cancer (such as revlimid) and expect the body to be able to regenerate. ~ I worry about my future with myeloma and about where I should be going to interact with others in case of infections etc. Research on this would be good. ~ Building their Immune system the giving of a more quality of life without loss of appetite, diarrhea ~ More focus on immune system re-programming to do it's compete job which was compromised with the initial onslaught of the disease? ~ Feeling that the immune system is back to normal (not just the cancer numbers) so the it permits you to live a normal active life again (e.g. travel and contact with public) without always worrying about risks. |
Submitted by | Please see the PSP Engagement Summary on the JLA website |
PSP information | |
---|---|
PSP unique ID | 0113 |
PSP name | Myeloma (Canada) |
Total number of uncertainties identified by this PSP. | 59 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
Date of priority setting workshop | 28 April 2021 |